Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S20 pseudogene 20 (RPS20P20) is a **processed pseudogene** related to the functional ribosomal protein S20 gene (RPS20), which encodes a component of the 40S ribosomal subunit involved in protein synthesis. RPS20P20 itself does not code for a functional protein, nor does it have evidence of a biological, disease-related, or therapeutic role. Pseudogenes such as RPS20P20 arise through gene duplication or retrotransposition events and are typically not transcribed into functional proteins[7]. The functional RPS20 gene, in contrast, is well-studied and associated with ribosome assembly and diseases such as familial colorectal cancer and Diamond-Blackfan anemia, but the pseudogene RPS20P20 has no known medical or therapeutic significance. **Key Point:** This entity is a pseudogene, not an active protein or therapeutic target, and should not be treated as such for research or drug discovery purposes[7].
None (pseudogenes do not encode proteins or serve as drug targets)[7]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S20 pseudogene 20 (RPS20P20).